Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade
Thomas W. Flaig, Maren Salzmann-Sullivan, Lih‐Jen Su, et al.
Oncotarget (2017) Vol. 8, Iss. 34, pp. 56051-56065
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential
Isabel R. Schlaepfer, Molishree Joshi
Endocrinology (2020) Vol. 161, Iss. 2
Open Access | Times Cited: 474
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Lisa M. Butler, Ylenia Perone, Jonas Dehairs, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 245-293
Open Access | Times Cited: 459
Lipid metabolism in cancer progression and therapeutic strategies
Yan Fu, Tiantian Zou, Xiaotian Shen, et al.
MedComm (2020) Vol. 2, Iss. 1, pp. 27-59
Open Access | Times Cited: 211
Emerging role of lipid metabolism alterations in Cancer stem cells
Mei Yi, Junjun Li, Shengnan Chen, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 203
Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment
Lara P. Fernández, Marta Gómez de Cedrón, Ana Ramı́rez de Molina
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 161
2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer
Arnaud Blomme, Catriona A. Ford, Ernest Mui, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 147
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis
Zeyad D. Nassar, Chui Y. Mah, Jonas Dehairs, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 146
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Muhammad Tufail, Canhua Jiang, Ning Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 51
When fats commit crimes: fatty acid metabolism, cancer stemness and therapeutic resistance
Ching‐Ying Kuo, David K. Ann
Cancer Communications (2018) Vol. 38, Iss. 1, pp. 1-12
Open Access | Times Cited: 138
Lipid Metabolism and Endocrine Resistance in Prostate Cancer, and New Opportunities for Therapy
Gergana E. Stoykova, Isabel R. Schlaepfer
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2626-2626
Open Access | Times Cited: 95
Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer Progression
Brandon T. Sawyer, Lubna Qamar, Tomomi M. Yamamoto, et al.
Molecular Cancer Research (2020) Vol. 18, Iss. 7, pp. 1088-1098
Open Access | Times Cited: 91
Lipid Metabolism and Resistance to Anticancer Treatment
Nicolas Germain, Mélanie Dhayer, M. Boileau, et al.
Biology (2020) Vol. 9, Iss. 12, pp. 474-474
Open Access | Times Cited: 90
Defective lysosome reformation during autophagy causes skeletal muscle disease
Meagan J. McGrath, Matthew J. Eramo, Rajendra Gurung, et al.
Journal of Clinical Investigation (2020) Vol. 131, Iss. 1
Open Access | Times Cited: 73
The emerging role of targeting cancer metabolism for cancer therapy
Pegah Farhadi, Reza Yarani, Sadat Dokaneheifard, et al.
Tumor Biology (2020) Vol. 42, Iss. 10, pp. 101042832096528-101042832096528
Open Access | Times Cited: 70
Lipid Metabolism in Glioblastoma: From De Novo Synthesis to Storage
Yongjun Kou, Feng Geng, Deliang Guo
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1943-1943
Open Access | Times Cited: 54
Targeting lipid metabolism in metastatic prostate cancer
Tahlia Scheinberg, Blossom Mak, Lisa M. Butler, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 22
Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies
Giulia Ambrosini, Marco Cordani, Ali Zarrabi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Metabolic adaptations in prostate cancer
Mikel Pujana-Vaquerizo, Laura Bozal-Basterra, Arkaitz Carracedo
British Journal of Cancer (2024) Vol. 131, Iss. 8, pp. 1250-1262
Open Access | Times Cited: 10
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer
Alessandro Alaimo, Sacha Genovesi, Nicole Annesi, et al.
The EMBO Journal (2024) Vol. 43, Iss. 5, pp. 780-805
Open Access | Times Cited: 8
The Metabolic Landscape of Prostate Cancer
Francesca Giunchi, Michelangelo Fiorentino, Massimo Loda
European Urology Oncology (2018) Vol. 2, Iss. 1, pp. 28-36
Closed Access | Times Cited: 81
Metabolism within the tumor microenvironment and its implication on cancer progression: An ongoing therapeutic target
Ma Carmen Ocaña, Beatriz Martínez‐Poveda, Ana R. Quesada, et al.
Medicinal Research Reviews (2018) Vol. 39, Iss. 1, pp. 70-113
Open Access | Times Cited: 74
Inhibition of collagen XI alpha 1-induced fatty acid oxidation triggers apoptotic cell death in cisplatin-resistant ovarian cancer
Sameera Nallanthighal, Miran Rada, James Patrick Heiserman, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 4
Open Access | Times Cited: 64
Androgen Receptor Signaling and Metabolic and Cellular Plasticity During Progression to Castration Resistant Prostate Cancer
Takuma Uo, Cynthia C.T. Sprenger, Stephen R. Plymate
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 57
The role and therapeutic implication of CPTs in fatty acid oxidation and cancers progression
Junmin Wang, Hongjiao Xiang, Yifei Lü, et al.
American Journal of Cancer Research (2021) Vol. 11, Iss. 6, pp. 2477-2494
Closed Access | Times Cited: 42
Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics
Soumik Pal, Amit Sharma, Sam Padalumavunkal Mathew, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top